DiagnosTear Technologies (DTR.CN) plans to raise up to C$1.4 million through a non-brokered private placement of up to 2.8-million share units priced at C$0.50 each, it said Monday.
Each unit will be made up of a share and a one-year warrant to buy a share for C$1.00, said the company.
The company expects its parent company BioLight Life Sciences and Elcam Medicald to each participate for up to one-third of the total offering.
The company will use the net proceeds for its working capital and general corporate purposes.